Connection

XIN LI to Animals

This is a "connection" page, showing publications XIN LI has written about Animals.
Connection Strength

0.139
  1. A proteolysis-targeting chimera molecule selectively degrades ENL and inhibits malignant gene expression and tumor growth. J Hematol Oncol. 2022 04 08; 15(1):41.
    View in: PubMed
    Score: 0.045
  2. Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy. J Hematol Oncol. 2020 05 13; 13(1):50.
    View in: PubMed
    Score: 0.040
  3. Recent developments in the discovery of novel antipsychotic agents modualating dopamine and serotonin receptors. Curr Drug Targets. 2013 Jul; 14(8):899-918.
    View in: PubMed
    Score: 0.025
  4. Small-molecule inhibitor of AF9/ENL-DOT1L/AF4/AFF4 interactions suppresses malignant gene expression and tumor growth. Theranostics. 2021; 11(17):8172-8184.
    View in: PubMed
    Score: 0.011
  5. Targeting MDM2 for novel molecular therapy: Beyond oncology. Med Res Rev. 2020 05; 40(3):856-880.
    View in: PubMed
    Score: 0.010
  6. Prevention of prostate cancer by natural product MDM2 inhibitor GS25: in vitro and in vivo activities and molecular mechanisms. Carcinogenesis. 2018 07 30; 39(8):1026-1036.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.